Anavex Life Sciences
AVXL
#8515
Rank
โ‚น24.34 B
Marketcap
โ‚น262.75
Share price
6.98%
Change (1 day)
-70.86%
Change (1 year)

Market capitalization of Anavex Life Sciences (AVXL)

Market cap: โ‚น24.34 Billion

As of July 2026 Anavex Life Sciences has a market cap of โ‚น24.34 Billion. This makes Anavex Life Sciences the world's 8515th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Anavex Life Sciences from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น24.34 B-16.6%
2025โ‚น29.19 B-66.87%
2024โ‚น88.11 B38.5%
2023โ‚น63.62 B6.5%
2022โ‚น59.73 B-39.11%
2021โ‚น98.11 B271%
2020โ‚น26.44 B150.84%
2019โ‚น10.54 B106.13%
2018โ‚น5.11 B-43.75%
2017โ‚น9.09 B-14.71%
2016โ‚น10.65 B-16.9%
2015โ‚น12.82 B1896.21%
2014โ‚น0.64 B10.53%
2013โ‚น0.58 B-55.56%
2012โ‚น1.30 B-25.45%
2011โ‚น1.75 B-57.31%
2010โ‚น4.10 B96.05%
2009โ‚น2.09 B-15.24%
2008โ‚น2.47 B-39.15%
2007โ‚น4.06 B77%
2006โ‚น2.29 B

End of Day market cap according to different sources

On Jul 2nd, 2026 the market cap of Anavex Life Sciences was reported to be:

โ‚น24.34 Billion
by Nasdaq info icon info icon
โ‚น24.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น609.67 B 2,403.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น921.93 B 3,686.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น1.96 B-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น238.09 B 877.80%๐Ÿ‡บ๐Ÿ‡ธ USA